Identification of Potential Inhibitors of SARS-CoV-2 Main Protease from Aloe Vera Compounds: A Molecular Docking Study

Pius T. Mpiana et al.

SARS-CoV-2 is the pathogen agent of the new corona virus disease that appeared at the end of 2019 in China. There is, currently, no effective treatment against COVID-19. We report in this study a molecular docking study of ten Aloe vera molecules with the main protease (3CLpro) responsible for the replication of coronaviruses. The outcome of their molecular simulation and ADMET properties reveal three potential inhibitors of the enzyme (ligands 6, 1 and 8) with a clear preference of ligand 6 that has the highest binding energy (−7.9 kcal/mol) and fully obeys the Lipinski’s rule of five.

Latest articles

Ana Sandolu … Scientists have unraveled the molecular underpinnings of cilantro’s anticonvulsive...
Maryanne Demasi Tom Jefferson, senior associate tutor at the University of Oxford,...
NCBI Bookshelf Choline has multiple roles as an essential nutrient. A major...
Emerging Technology from the arXiv In recent years, a growing body of...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!